Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.83EUR
9.56 MEUR
16.06 MEUR
4.29 M
About BIOVENTIX PLC ORD GBP0.05
Sector
CEO
Peter J. Harrison
Website
Headquarters
Farnham
Founded
2003
ISIN
GB00B4QVDF07
FIGI
Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 51B is 37.80 EUR — it has decreased by −5.56% in the past 24 hours. Watch BIOVENTIX PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange BIOVENTIX PLC stocks are traded under the ticker 51B.
51B stock has fallen by −11.37% compared to the previous week, the month change is a −17.26% fall, over the last year BIOVENTIX PLC has showed a −22.22% decrease.
We've gathered analysts' opinions on BIOVENTIX PLC future price: according to them, 51B price has a max estimate of 61.15 EUR and a min estimate of 61.15 EUR. Watch 51B chart and read a more detailed BIOVENTIX PLC stock forecast: see what analysts think of BIOVENTIX PLC and suggest that you do with its stocks.
51B stock is 7.61% volatile and has beta coefficient of 0.07. Track BIOVENTIX PLC stock price on the chart and check out the list of the most volatile stocks — is BIOVENTIX PLC there?
Today BIOVENTIX PLC has the market capitalization of 203.99 M, it has decreased by −3.59% over the last week.
Yes, you can track BIOVENTIX PLC financials in yearly and quarterly reports right on TradingView.
BIOVENTIX PLC is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
51B net income for the last half-year is 4.81 M EUR, while the previous report showed 4.64 M EUR of net income which accounts for 3.60% change. Track more BIOVENTIX PLC financial stats to get the full picture.
BIOVENTIX PLC dividend yield was 3.52% in 2024, and payout ratio reached 99.92%. The year before the numbers were 3.95% and 94.63% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOVENTIX PLC EBITDA is 12.64 M EUR, and current EBITDA margin is 78.72%. See more stats in BIOVENTIX PLC financial statements.
Like other stocks, 51B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOVENTIX PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOVENTIX PLC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOVENTIX PLC stock shows the strong sell signal. See more of BIOVENTIX PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.